rs200450661

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_005379.4(MYO1A):​c.1928G>A​(p.Arg643Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,614,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000040 ( 0 hom. )

Consequence

MYO1A
NM_005379.4 missense

Scores

1
18

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.677

Publications

1 publications found
Variant links:
Genes affected
MYO1A (HGNC:7595): (myosin IA) This gene encodes a member of the myosin superfamily. The protein represents an unconventional myosin; it should not be confused with the conventional skeletal muscle myosin-1 (MYH1). Unconventional myosins contain the basic domains characteristic of conventional myosins and are further distinguished from class members by their tail domains. They function as actin-based molecular motors. Mutations in this gene have been associated with autosomal dominant deafness. Alternatively spliced variants have been found for this gene. [provided by RefSeq, Dec 2011]
MYO1A Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.059339494).
BP6
Variant 12-57037902-C-T is Benign according to our data. Variant chr12-57037902-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 164589.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO1ANM_005379.4 linkc.1928G>A p.Arg643Gln missense_variant Exon 18 of 28 ENST00000300119.8 NP_005370.1 Q9UBC5
MYO1ANM_001256041.2 linkc.1928G>A p.Arg643Gln missense_variant Exon 19 of 29 NP_001242970.1 Q9UBC5B2R643
MYO1AXM_047428876.1 linkc.1928G>A p.Arg643Gln missense_variant Exon 19 of 29 XP_047284832.1
MYO1AXM_011538373.3 linkc.1928G>A p.Arg643Gln missense_variant Exon 18 of 25 XP_011536675.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO1AENST00000300119.8 linkc.1928G>A p.Arg643Gln missense_variant Exon 18 of 28 1 NM_005379.4 ENSP00000300119.3 Q9UBC5
MYO1AENST00000442789.6 linkc.1928G>A p.Arg643Gln missense_variant Exon 19 of 29 1 ENSP00000393392.2 Q9UBC5
MYO1AENST00000554234.5 linkn.1442G>A non_coding_transcript_exon_variant Exon 14 of 24 5 ENSP00000451033.1 G3V342

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152172
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000319
AC:
8
AN:
250974
AF XY:
0.0000221
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000617
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000397
AC:
58
AN:
1461862
Hom.:
0
Cov.:
33
AF XY:
0.0000371
AC XY:
27
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.000448
AC:
15
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000306
AC:
34
AN:
1112000
Other (OTH)
AF:
0.0000497
AC:
3
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152290
Hom.:
0
Cov.:
32
AF XY:
0.0000403
AC XY:
3
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41562
American (AMR)
AF:
0.00
AC:
0
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68034
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000823
Hom.:
0
Bravo
AF:
0.0000491
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000247
AC:
3
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 18, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Arg643Gln in exon 18 of MYO1A: This variant is not expected to have clinical significance because the arginine (Arg) residue at position 643 is not conserved in mammals or across species, with guinea pig and rabbit having a glutamine (Gl n). In addition, recent evidence has disqualified an association between variant s in the MYO1A gene and hearing loss (Eisenberger 2014). This variant has also been identified in 0.5% (1/192) of Kenyan chromosomes by the 1000 Genomes Projec t (rs200450661). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.19
T;T
Eigen
Benign
-0.53
Eigen_PC
Benign
-0.44
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.66
.;T
M_CAP
Benign
0.033
D
MetaRNN
Benign
0.059
T;T
MetaSVM
Benign
-0.52
T
MutationAssessor
Benign
0.89
L;L
PhyloP100
0.68
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.69
N;N
REVEL
Benign
0.19
Sift
Benign
0.21
T;T
Sift4G
Benign
0.34
T;T
Polyphen
0.016
B;B
Vest4
0.18
MVP
0.74
MPC
0.096
ClinPred
0.049
T
GERP RS
2.3
Varity_R
0.096
gMVP
0.20
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200450661; hg19: chr12-57431686; API